Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 6 Magnetic Resonance Spectroscopy 6 Biopsy 6 Doxorubicin 5 X-Rays 4 Phantoms, Imaging 4 Nuclear Medicine Department, Hospital 4 Cyclophosphamide 4 pembrolizumab 3 liposomal doxorubicin 3 fludarabine 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 fludarabine phosphate 2 ensartinib 2 atezolizumab 2 anlotinib 2 Temozolomide 2 Radiation 2 Irinotecan 2 Ifosfamide 2 Carboplatin 2 Bevacizumab 2 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Conservative Treatment × 30 days × Clear all

NCT06022159 2026-06-02

HYPOSARC

Institut Claudius Regaud

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡